Lukoon

India Keratoconus Treatment Market Size, Share, and Forecast to 2035

2 min read
0
Comments
26
Views

From Custom Contact Lenses to Advanced Surgical Interventions

Managing keratoconus requires a tailored approach based on disease severity, corneal thickness, and visual requirements. Treatment options range from non-invasive optical corrections in early stages to surgical procedures for advanced corneal thinning.

Primary therapeutic and interventional categories include:

  • Custom Contact Lenses: Rigid Gas Permeable (RGP), hybrid, and scleral contact lenses are widely prescribed to bridge the irregular corneal surface and provide sharp optics.

  • Corneal Collagen Cross-Linking (CXL): A minimally invasive procedure utilizing riboflavin (vitamin B2) drops activated by ultraviolet-A (UVA) light to strengthen corneal collagen bonds and stop cone progression.

  • Intrastromal Corneal Ring Segments (ICRS): Arc-shaped PMMA implants inserted into the deep corneal stroma to flatten the cone and improve uncorrected visual acuity.

  • Corneal Transplantation: Penetrating Keratoplasty (PK) or Deep Anterior Lamellar Keratoplasty (DALK) performed in end-stage cases with dense scarring or severe thinning.

Treatment Type Primary Goal Clinical Stage Key Advantage
Scleral Lenses Visual Rehabilitation Early to Moderate Vaults over cornea, high comfort & stability
Epithelium-Off CXL Disease Stabilization Progressive Keratoconus Proven long-term efficacy in halting ectasia
Accelerated CXL Rapid Stabilization Progressive Keratoconus Shorter treatment time, higher patient throughput
DALK / Keratoplasty Structural Reconstruction Advanced / End-Stage Replaces diseased tissue while preserving endothelium

Selecting the right combination of therapies depends on corneal thickness and disease activity. Ophthalmic researchers and strategic planners looking for detailed category breakdowns can review the dedicated india keratoconus treatment market study.